Skip to content

How to Use Epithalon (Epitalon): Administration, Reconstitution & Storage (2026)

From Peptidepedia, the trusted peptide wiki.

How to Use / Administration Methods

Subcutaneous Injection (Standard Route): Epithalon is administered via subcutaneous injection into the abdominal region, thigh, or upper arm. Rotate injection sites systematically to prevent lipohypertrophy. Use an insulin syringe for accurate dosing.

Sublingual Administration: Some research protocols have used sublingual Epithalon delivery, including the melatonin study involving 75 women. Bioavailability via sublingual route compared to injection has not been rigorously characterized.

Intranasal Administration: Nasal spray formulations have been explored in limited research settings. Absorption and efficacy data for intranasal delivery are insufficient to make dosing recommendations.

Reconstitution: Epithalon is supplied as a lyophilized (freeze-dried) white powder requiring reconstitution before injection.

  1. Allow the vial to reach room temperature
  2. Draw bacteriostatic water (0.9% benzyl alcohol) into a sterile syringe
  3. Inject the water slowly along the interior vial wall, do not jet directly onto the powder
  4. Gently swirl until fully dissolved; do not shake
  5. Inspect the solution for clarity. It should be clear and colorless

Common Reconstitution Ratio:

  • 10 mg Epithalon + 1 mL bacteriostatic water = 10 mg/mL (1:1 ratio)
  • Each 0.1 mL (10 units on an insulin syringe) = 1 mg

Storage:

  • Lyophilized powder: Stable for up to 3 years at -20°C, up to 2 years at 2 to 8°C
  • Reconstituted solution: Refrigerate at 2 to 8°C, use within 6 weeks, protect from light
  • Discard if solution becomes cloudy, discolored, or contains particulate matter

Reconstitution, Storage & Prep

Epithalon is supplied as a lyophilized white powder requiring reconstitution before subcutaneous injection.

Reconstitution Process:

  1. Allow the vial to reach room temperature before opening
  2. Use bacteriostatic water (0.9% benzyl alcohol) as the reconstitution vehicle
  3. Draw the appropriate volume of bacteriostatic water into an insulin syringe
  4. Insert the needle through the stopper and inject water slowly along the interior vial wall
  5. Gently swirl until powder is fully dissolved, do not shake
  6. Inspect the solution; it should be clear and colorless

Reconstitution Ratio (1:1):

  • 10 mg Epithalon + 1 mL bacteriostatic water = 10 mg/mL
  • For a 5 mg dose: draw 0.5 mL (50 units on an insulin syringe)
  • For a 10 mg dose: draw 1.0 mL (100 units on an insulin syringe)

Storage Guidelines:

  • Lyophilized (unreconstituted): Up to 3 years at -20°C; up to 2 years at 2 to 8°C
  • Reconstituted solution: Store at 2 to 8°C (refrigerator); use within 6 weeks
  • Protect from light at all times
  • Do not freeze reconstituted solution
  • Discard if the solution becomes cloudy, discolored, or contains particulate matter

Frequently Asked Questions

Animal studies from Khavinson's group reported maximum lifespan extensions of approximately 13% in SHR mice and reduced tumor incidence in certain mouse strains. However, these results have not been independently replicated by Western laboratories, and no controlled human longevity trials have been conducted.

Research protocols typically use 5 to 10 mg per day via subcutaneous injection for 10 to 20 consecutive days, repeated once or twice per year. No FDA-approved dosing guidelines exist, and optimal dosing in humans has not been established through rigorous clinical trials.

Reported side effects are generally mild and include injection site reactions, transient headache, and drowsiness potentially related to melatonin modulation. Long-term safety data is limited, and theoretical concerns exist regarding telomerase activation in individuals with undetected malignancies.

Research protocols typically administer Epithalon for 10 to 20 consecutive days per cycle, with cycles repeated every 4 to 6 months. Continuous long-term use has not been studied. The intermittent cycling approach is based on the hypothesis that the peptide resets regulatory pathways rather than requiring sustained exposure.

This content is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions.

References

  1. Khavinson VK, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-592.
  2. Khavinson VK, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003;24(3-4):233-240.
  3. Anisimov VN, et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4(4):193-202.
  4. Anisimov VN, et al. Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int J Cancer. 2002;101(1):7-10.
  5. Khavinson VK, et al. Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly people. Adv Gerontol. 2007;20(1):74-85.
  6. Khavinson VK, et al. Pineal peptides restore the age-related disturbances in hormonal functions of the pineal gland and the pancreas. Exp Gerontol. 2005;40(1-2):51-57.
  7. Anisimov VN, et al. Effect of epithalon on the incidence of chromosome aberrations in senescence-accelerated mice. Bull Exp Biol Med. 2002;133(3):274-276.
  8. Khavinson VK. Peptides and ageing. Neuro Endocrinol Lett. 2002;23(Suppl 3):11-144.
  9. Al-Dulaimi S, Thomas R, Matta S, Roberts T. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology. 2025;26(5):178.
  10. Kossoy G, et al. Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors and mucosa. Int J Mol Med. 2003;12(4):473-477.

“Peptidepedia compiles and maintains peptide information from peer-reviewed research, clinical trials, and verified laboratory data.”